Vasil S. Boyanov

Dr. Vasil S. Boyanov

Medical Microbiology, Medical University of Sofia, Sofia, Sofia-Grad, Bulgaria
orcid
MD, MPH, PhD

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
RGRaina Tzvetanova Gergova
Raina Tzvetanova Gergova
Vasil S. BoyanovVasil S. Boyanov
Vasil S. Boyanov
AMAdile Muhtarova
Adile Muhtarova
AAAlexandra Alexandrova
Alexandra Alexandrova
Streptococcus pneumoniae, Streptococcus pyogenes (GAS), and Streptococcus agalactiae (GBS) are bacteria that can cause a range of infections, some of them life-threatening. This review examines the spread of antibiotic resistance and its mechanisms against antibiotics for streptococcal infections. Data on high-level penicillin-resistant invasive pneumococci have been found in Brazil (42.8%) and Japan (77%). The resistance is caused by mutations in genes that encode penicillin-binding proteins. Similarly, GAS and GBS strains reported from Asia, the USA, and Africa have undergone similar transformations in PBPs. Resistance to major alternatives of penicillins, macrolides, and lincosamides has become widespread among pneumococci and streptococci, especially in Asia (70–95%). The combination of several emm types with erm(B) is associated with the development of high-level macrolide resistance in GAS. Major mechanisms are ribosomal target modifications encoded by erm genes, ribosomal alterations, and active efflux pumps that regulate antibiotic entry due to mefA/E and msrD genes. Tetracycline resistance for streptococci in different countries varied from 22.4% in the USA to 83.7/100% in China, due to tet genes. Combined tetracycline/macrolide resistance is usually linked with the insertion of ermB into the transposon carrying tetM. New quinolone resistance is increasing by between 11.5 and 47.9% in Asia and Europe. The mechanism of quinolone resistance is based on mutations in gyrA/B, determinants for DNA gyrase, or parC/E encoding topoisomerase IV. The results for antibiotic resistance are alarming, and urgently call for increased monitoring of this problem and precautionary measures for control to prevent the spread of resistant mutant strains.

17 February 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Ivo Nikolaev Sirakov, PhDIvo Nikolaev Sirakov, PhD
Ivo Nikolaev Sirakov, PhD
Tanya StratevaTanya Strateva
Tanya Strateva
Vasil S. BoyanovVasil S. Boyanov
Vasil S. Boyanov
POPetya Stefanova Orozova
Petya Stefanova Orozova
DYDaniel Yordanov
Daniel Yordanov
IMIvan Mitov
Ivan Mitov
Lactococcosis caused by Lactococcus garvieae is a bacterial infection affecting fish with a considerable economic impact. Recently, L. garvieae has established itself as an opportunistic pathogen in humans. The aim of the current study was to test classical and molecular-biological methods for the identification of L. garvieae and examine antimicrobial susceptibility and capsule production, an important virulence factor. Additionally, tests for differentiation from closely related species, as well as epidemiological typing, were performed. In a period of 18 years (2002–2019), 24 isolates presumptively identified as L. garvieae were collected from Oncorhynchus mykiss and Salmo salar fish obtained either from retail stores or fish farms. In order to confirm the species, optimized PCR-based protocols were used. As a result, 21 of the tested strains were proved to be L. garvieae (n = 21). The remaining three isolates were Lactococcus lactis, Streptococcus iniae, and Enterococcus faecalis. Epidemiological typing by randomly amplified polymorphic DNA was performed. Except for a single KG+ isolate, all other strains belonged to the European capsular serotype KG−. All L. garvieae isolates showed susceptibility to all tested antibiotics with the exception of clindamycin, which was a diagnostic sign. A thorough optimization of diagnostic methods is essential to determining the etiology of specific infections affecting the personnel at risk in fish farms, the food industry, or within the broader community.

1 December 2024 in Polish Journal of Microbiology
Verified
Journal Article
Open access
PDF file
Vasil S. BoyanovVasil S. Boyanov
Vasil S. Boyanov
AAAlexandra Alexandrova
Alexandra Alexandrova
PHPreslava Hristova
Preslava Hristova
HHHristina Y. Hitkova
Hristina Y. Hitkova
RGRaina Tzvetanova Gergova
Raina Tzvetanova Gergova
Streptococcus agalactiae ( group B Streptococcus , GBS) is an important human and animal pathogen. In recent years, the number of streptococcal isolates resistant to antimicrobial agents has increased in many parts of the world. Various mechanisms of antimicrobial resistance and capsular serotypes of GBS with different geographical distributions can be found. A prospective cross-sectional study was conducted from September 2021 to May 2024. The survey included 257 GBS isolates from Bulgarian inpatients and outpatients with streptococcal infections. Antibiotic resistance genes and capsular serotypes were detected and evaluated using polymerase chain reaction (PCR). We classified GBS isolates into groups according to their source as vaginal samples (191) and extra-vaginal samples (66), subdivided as invasive (36) and non-invasive specimens (30). The most common serotypes were Ia (26.5%), III (20.2%), and V (19.8%). Antimicrobial susceptibility testing revealed that all examined isolates were susceptible to penicillin and vancomycin. Resistance to macrolides, lincosamides, and tetracyclines was observed in 60.3%, 24.9%, and 89.1% of the isolates. The distribution of phenotypes was cMLSb 47.4%, iMLSb 30.8%, M-type 21.2%, and L-type 0.6%. PCR analysis revealed nine genes associated with macrolide and lincosamide resistance: ermB (54.2%), ermA / TR (30.3%), mefA (20.7%), ermC (18.1%), msrD (14.8%), mefE (8.4%), IsaC (8.4%), InuB (7.7%), and IsaE (6.5%). Two genes linked to tetracycline resistance tetM (89.1%) and tetO (14.4%) were detected. Compared to the previous period, we observed increased antibiotic resistance. There was no statistical significance between the distribution of serotypes and antimicrobial non-susceptibility depending on the sample source.

Verified
Journal Article
Open access
PDF file
AAAlexandra Alexandrova
Alexandra Alexandrova
Vasil S. BoyanovVasil S. Boyanov
Vasil S. Boyanov
KMKalina Mihova
Kalina Mihova
RGRaina Gergova
Raina Gergova
Moraxella catarrhalis has been recognized as an important cause of upper respiratory tract and middle ear infections in children, as well as chronic obstructive pulmonary disease and chronic bronchitis in adults. We aim to study the clonal structure, antimicrobial resistance, and serotypes of M. catarrhalis strains recovered from patients of different ages. Nasopharyngeal swabs, middle ear fluid, and sputum samples were collected. In vitro susceptibility testing was performed according to EUCAST criteria. The monoclonal Ab hybridoma technique was used for serotyping. All strains were subjected to MLST. The studied population demonstrated susceptibility to all tested antimicrobials M. catarrhalis strains, with the majority being serotype A (90.4%), followed by B (6.8%), and C (2.7%). We observed a predominant clonal complex CC224 (21.9%) along with other clusters including CC141 (8.2%), CC184 (8.2%), CC449 (6.8%), CC390 (5.5%), and CC67 (2.7%). Two primary founders, namely, ST224 and ST141, were identified. The analyzed genetic lineages displayed diversity but revealed the predominance of two main clusters, CC224 and CC141, encompassing multidrug-resistant sequence types distributed in other regions. These data underscore the need for ongoing epidemiological monitoring of successfully circulating clones and the implementation of adequate antibiotic policies to limit or delay the spread of multidrug-resistant strains in our region.

12 May 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
AAAlexandra Alexandrova
Alexandra Alexandrova
Vasil S. BoyanovVasil S. Boyanov
Vasil S. Boyanov
LBLiliya Yordanova Boyanova
Liliya Yordanova Boyanova
RGRaina Tzvetanova Gergova
Raina Tzvetanova Gergova
Background: The use of plant-derived agents is a common approach in integrative care for respiratory conditions. However, the evidence of clinical trials has not yet been comprehensively presented. Aim: To summarize the antibacterial, antiviral, immunomodulatory, antioxidant, and expectorant properties of Echinacea spp., Pelargonium sidoides, Hedera helix, Thymus vulgaris, Althaea officinalis, Sambucus nigra, Zingiber officinale, and Curcuma longa, and to evaluate the evidence level from clinical trials (CTs) involving these agents in patients with respiratory tract infections (RTIs). Methods: We conducted a literature search using the PubMed database focusing on clinical studies of plant-derived agents in upper and lower RTIs. PRISMA-based reporting elements were used only as a guiding tool for comprehensibility of the literature search (Reporting Items for Systematic Reviews and Meta-Analyses guidelines). Results: A summary and structured overview of the properties of these most-cited plant-derived agents in the literature, in the context of RTIs, was provided. A total of 94 reports met the eligibility criteria and were included in our review. Of these, 66 reported randomized and placebo-controlled trials investigating the efficacy and tolerability of these adjuncts in patients with RTIs. The non-randomized and uncontrolled trials were 22. Sufficient evidence to be regarded as an appropriate treatment to reduce the severity and duration of RTIs was found for all discussed plant-derived agents. Robust evidence available was found for Echinacea spp., Pelargonium sidoides, Sambucus nigra, Curcuma longa and Zingiber officinale. Conclusions: Regarding other plant-derived agents reported in the traditional medicine for the treatment of RTIs, further research is needed to clarify the evidence gaps.

15 September 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
AMAdile Muhtarova
Adile Muhtarova
Vasil S. BoyanovVasil S. Boyanov
Vasil S. Boyanov
AAAlexandra Alexandrova
Alexandra Alexandrova
RGRaina Tzvetanova Gergova
Raina Tzvetanova Gergova
In recent years, the incidence of severe Streptococcus pyogenes (group A Streptococcus, GAS) infections has been increasing worldwide, similar to trends observed prior to the COVID-19 pandemic, alongside a rise in antibiotic resistance. In the present study, we identified the circulating 12 emm types and 8 clusters of 70 GAS isolates among inpatients, investigated their association with antibiotic susceptibility, and compared these findings with earlier research conducted in our country. The predominant emm types and clusters were emm1, emm3, and emm4, and A-C3, E4, and, A-C5, respectively. emm1 was the most common among patients with skin and soft tissue infections or pneumonia, while emm3 was detected in patients with peritonsillar abscesses. All isolates demonstrated susceptibility to penicillin and linezolid, whereas the prevalence of resistance to macrolides, lincosamides, and tetracyclines was found to be 14.3%, 14.3%, and 18.6%, respectively. A notable change in the distribution of emm-types/clusters has been observed, with emm1/A-C3 now identified as the most prevalent, differing from our previous study conducted in the pre-COVID-19 period. Additionally, we noted a decrease in resistance to macrolides attributed to a lower prevalence of emm28 clone. The current research is important for monitoring isolates responsible for severe infections, which is crucial for GAS surveillance.